Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-
about
Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and safety of fixed-d ...... factorial-design study (OLSTA-
@en
Efficacy and safety of fixed-d ...... factorial-design study (OLSTA-
@nl
type
label
Efficacy and safety of fixed-d ...... factorial-design study (OLSTA-
@en
Efficacy and safety of fixed-d ...... factorial-design study (OLSTA-
@nl
prefLabel
Efficacy and safety of fixed-d ...... factorial-design study (OLSTA-
@en
Efficacy and safety of fixed-d ...... factorial-design study (OLSTA-
@nl
P2093
P2860
P356
P1476
Efficacy and safety of fixed-d ...... an rosuvaSTAtin from Daewoong)
@en
P2093
Chang-Wook Nam
Hong-Seog Seo
Hyo-Soo Kim
Jin-Sun Park
Joon-Han Shin
Min-Su Hyon
Sang-Chol Lee
Sang-Hong Baek
Sang-Hyun Kim
Tae-Ho Park
P2860
P304
P356
10.2147/DDDT.S112873
P407
P577
2016-08-16T00:00:00Z